Goldman Sachs’s Silexion Therapeutics Corp Warrant SLXNW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.65K	Buy	113,568 +3,476	+3%	+$142	﹤0.01%	5085
2025 Q1	$8.42K	Buy	110,092 +2,617	+2%	+$200	﹤0.01%	5010
2024 Q4	$3.64K	Buy	107,475 +14,188	+15%	+$481	﹤0.01%	4973
2024 Q3	$2.94K	Buy	+93,287	New	+$2.94K	﹤0.01%	4784